Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
Rhea-AI Summary
Progyny (Nasdaq: PGNY) will report financial results for the quarter ended September 30, 2025 after market close on Thursday, November 6, 2025.
The company will host a conference call at 4:45 P.M. ET / 1:45 P.M. PT the same day and will issue a press release before the call. U.S. dial-in: 1.866.825.7331 (passcode 265484); international dial-in: 1.973.413.6106. Audio replay available through Thursday, November 13, 2025. Live webcast and archive at http://investors.progyny.com.
Progyny provides employer-focused women’s health and family building benefits and is headquartered in New York City. For investor inquiries: investors@progyny.com.
Positive
- None.
Negative
- None.
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, 2025 after the close of the market on Thursday, November 6, 2025.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Thursday, November 13, 2025 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans, and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
When will Progyny (PGNY) report third quarter 2025 results?
What time is the Progyny (PGNY) Q3 2025 conference call and how can I join?
Where can I find the Progyny (PGNY) webcast and archived earnings presentation?
How long is the Progyny (PGNY) earnings call replay available and how do I access it?
Who should I contact for investor questions about Progyny (PGNY)?
